Get the Stockscreener App
0.6886
2.21%
0.0149
After Hours:
.69
0.0014
+0.20%
Harvard Bioscience Inc Stock (HBIO) Latest News
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges - Investing.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Harvard Bioscience Reports 2024 Financial Results - TipRanks
Harvard Bioscience Navigates Growth Amid Challenges - TipRanks
Harvard Bioscience secures waiver for credit covenant By Investing.com - Investing.com Australia
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 - GlobeNewswire
Harvard Bioscience CEO to Host Fireside Chats at Roth and KeyBanc Healthcare Forums - StockTitan
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire
Earnings call transcript: Harvard Bioscience Q4 2024 beats expectations but faces market challenges - Investing.com
Harvard Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Harvard Bioscience slumps after weak revenue forecast - TradingView
HARVARD BIOSCIENCE Earnings Results: $HBIO Reports Quarterly Earnings - Nasdaq
Harvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last year - TipRanks
Harvard Bioscience earnings beat, revenue topped estimates By Investing.com - Investing.com UK
Harvard Bioscience Achieves Profit Turnaround Despite Revenue Challenges in Latest Quarter - StockTitan
Harvard Bioscience IncQ4 2024 Revenues $24.6 Million -March 12, 2025 at 07:04 am EDT - Marketscreener.com
Harvard Bioscience Q4 and Full-Year 2024 Financial Results - TradingView
Harvard Bioscience secures waiver for credit covenant - Investing.com
Harvard BioscienceExploring Alternative Capital Sources For Refinancing Outstanding Indebtedness By June 30 - Marketscreener.com
Costco Price Plunge Equals Opportunity for Investors - The Globe and Mail
Harvard Bioscience (HBIO) Expected to Announce Earnings on Wednesday - Armenian Reporter
Harvard Bioscience, Inc. to Host Earnings Call - ACCESS Newswire
HBIO stock touches 52-week low at $0.86 amid market challenges - Investing.com Australia
BioAtla Inc (BCAB) shows promising results - US Post News
Dycom Industries, Inc. to Participate in Upcoming Investor Conferences - The Manila Times
Harvard Bioscience to Showcase Latest Solutions for - GlobeNewswire
Can These New Research Platforms Transform Toxicology Studies? Harvard Bioscience Reveals Latest Innovations - StockTitan
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET - The Manila Times
Harvard Bioscience, Inc. to Announce Q4 2024 Financial Results on March 12, 2025 - Nasdaq
How to Access Harvard Bioscience's Critical Q4 2024 Financial Results Call - StockTitan
5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - MSN
NAYA Biosciences Announces Nomination of New Board Members - The Manila Times
Harvard Bioscience stock hits 52-week low at $1.23 By Investing.com - Investing.com Canada
BostInno✈️ Net-zero aviation fuel | MassVentures' deep tech investments - The Business Journals
HBIO stock touches 52-week low at $1.3 amid sharp annual decline - Investing.com Australia
Preclinical Software for Physiology DA and AS Market to Grow by USD 4.38 Billion from 2025-2029, Driven by Bioinformatics Tools in Research, AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Electroporation Instruments Market Growth 2025: Key Industry Trends, Share and Demand by 2033 - WICZ
Harvard Bioscience Inc (HBIO) Stock Sees a-10.84 Decrease - The News Heater
OceanFirst Financial Corp (OCFC) vs. Its Peers: A Comparison - The News Heater
Why Investors Shouldn't Be Surprised By Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 31% Share Price Plunge - Simply Wall St
Harvard Bioscience, Inc. (NASDAQ:HBIO) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough - Simply Wall St
JPMorgan Chase & Co. Makes New $75,000 Investment in WEBTOON Entertainment Inc. (NASDAQ:WBTN) - Defense World
JPMorgan Chase & Co. Boosts Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.7 amid market challenges - Investing.com India
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 22.8% in January - MarketBeat
NEW IQ/OQ for Biochrom NanoVue Plus Micro-Volume Spectrophotometer - Lab Manager Magazine
Assenagon Asset Management S.A. Sells 132,516 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO Stock Touches 52-Week Low at $1.79 Amid Market Challenges - Investing.com Canada
HBIO Stock Touches 52-Week Low at $1.79 Amid Market Challenges By Investing.com - Investing.com South Africa
Microelectrode Array In Vitro Market to Reach US$ 25.67 Million by 2031, Driven by Neuroscience and Animal Testing Alternatives - GlobeNewswire Inc.
0.98%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):